{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:38:49Z","timestamp":1793263129808,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30-AG028716"],"award-info":[{"award-number":["P30-AG028716"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.joca.2021.04.019","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T21:47:46Z","timestamp":1631742466000},"page":"1159-1173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Clinical monitoring in osteoarthritis: Biomarkers"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8173-8258","authenticated-orcid":false,"given":"V.B.","family":"Kraus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2021.04.019_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.joca.2010.01.012","article-title":"Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria","volume":"18","author":"van Spil","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib2","series-title":"Biochemical Markers","author":"Rousseau","year":"2012"},{"key":"10.1016\/j.joca.2021.04.019_bib3","series-title":"History of Radiography","year":"2020"},{"key":"10.1016\/j.joca.2021.04.019_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2474-9-116","article-title":"The discordance between clinical and radiographic knee osteoarthritis: a systematic search and summary of the literature","volume":"9","author":"Bedson","year":"2008","journal-title":"BMC Muscoskel Disord"},{"key":"10.1016\/j.joca.2021.04.019_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.50.7.467","article-title":"Clinical signs of early osteoarthritis: reproducibility and relation to x ray changes in 541 women in the general population","volume":"50","author":"Hart","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2021.04.019_bib6","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.joca.2010.02.014","article-title":"Summary of the OA biomarkers workshop 2009--biochemical biomarkers: biology, validation, and clinical studies","volume":"18","author":"Kraus","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.semarthrit.2017.08.006","article-title":"Toward classification criteria for early osteoarthritis of the knee","volume":"47","author":"Luyten","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.joca.2021.04.019_bib8","first-page":"22","article-title":"An evidence-based systematic review of human knee post-traumatic osteoarthritis (PTOA): timeline of clinical presentation and disease markers, comparison of knee joint PTOA models and early disease implications","author":"Khella","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.joca.2021.04.019_bib9","first-page":"100781","article-title":"Biochemical marker research in hemophilic arthropathy: a systematic review","author":"van Bergen","year":"2020","journal-title":"Blood Rev"},{"key":"10.1016\/j.joca.2021.04.019_bib10","series-title":"Rheumatology E-Book","article-title":"Rare Osteoarthritis: Ochronosis and Kashin-Beck Disease","author":"Kraus","year":"2019"},{"key":"10.1016\/j.joca.2021.04.019_bib11","doi-asserted-by":"crossref","first-page":"18913","DOI":"10.1074\/jbc.M111.298968","article-title":"Quantitative proteomic analysis of eight cartilaginous tissues reveals characteristic differences as well as similarities between subgroups","volume":"287","author":"Onnerfjord","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.joca.2021.04.019_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax3203","article-title":"Analysis of \"old\" proteins unmasks dynamic gradient of cartilage turnover in human limbs","volume":"5","author":"Hsueh","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.joca.2021.04.019_bib13","series-title":"Rheumatology E-Book","article-title":"Preclinical and Early Osteoarthritis","author":"Kraus","year":"2019"},{"key":"10.1016\/j.joca.2021.04.019_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrrheum.2013.14","article-title":"Mechanistic biomarkers for clinical decision making in rheumatic diseases","volume":"9","author":"Robinson","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.joca.2021.04.019_bib15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/jnci\/58.4.875","article-title":"Influence of renal insufficiency on levels of serum ribonuclease in patients with multiple myeloma","volume":"58","author":"Karpetsky","year":"1977","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.joca.2021.04.019_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00118992","article-title":"Incorporation of the biomarker concept in ecotoxicology calls for a redefinition of terms","volume":"5","author":"Van Gestel","year":"1996","journal-title":"Ecotoxicology"},{"key":"10.1016\/j.joca.2021.04.019_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"NIH","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.joca.2021.04.019_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.joca.2006.04.001","article-title":"Classification of osteoarthritis biomarkers: a proposed approach","volume":"14","author":"Bauer","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.joca.2010.08.019","article-title":"Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis","volume":"19","author":"Kraus","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib20","series-title":"BEST (Biomarkers, EndpointS, and Other Tools) Resource","year":"2016"},{"key":"10.1016\/j.joca.2021.04.019_bib21","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.joca.2015.03.002","article-title":"OARSI Clinical Trials Recommendations: soluble biomarker assessments in clinical trials in osteoarthritis","volume":"23","author":"Kraus","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jmoldx.2019.04.002","article-title":"Diagnostics reform and harmonization of clinical laboratory testing","volume":"21","author":"Schreier","year":"2019","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.joca.2021.04.019_bib23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrd.2017.72","article-title":"Bridging the translational innovation gap through good biomarker practice","volume":"16","author":"van Gool","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.joca.2021.04.019_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.joca.2021.04.019_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/1177271920974652","article-title":"Biomarkers: opportunities and challenges for drug development in the current regulatory landscape","volume":"15","author":"Gromova","year":"2020","journal-title":"Biomark Insights"},{"key":"10.1016\/j.joca.2021.04.019_bib26","series-title":"The Four Types of Validity","author":"Middleton","year":"2021"},{"key":"10.1016\/j.joca.2021.04.019_bib27","doi-asserted-by":"crossref","first-page":"100059","DOI":"10.1016\/j.ocarto.2020.100059","article-title":"Disease modification in osteoarthritis; pathways to drug approval","volume":"2","author":"Katz","year":"2020","journal-title":"Osteoarthritis Cartilage Open"},{"key":"10.1016\/j.joca.2021.04.019_bib28","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.2106\/JBJS.19.00439","article-title":"Addressing Disparities in Total Hip Replacement Outcomes: commentary on an article by Kanu Okike, MD, MPH, et\u00a0al.: \"Association of Race and Ethnicity with Total Hip Arthroplasty Outcomes in a Universally Insured Population\"","volume":"101","author":"Ansell","year":"2019","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.joca.2021.04.019_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41584-018-0005-9","article-title":"Biomarkers as drug development tools: discovery, validation, qualification and use","volume":"14","author":"Kraus","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.joca.2021.04.019_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3899\/jrheum.140382","article-title":"The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive","volume":"42","author":"Orlowsky","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.joca.2021.04.019_bib31","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.joca.2019.07.009","article-title":"Type II collagen peptide Coll2-1 is an actor of synovitis","volume":"27","author":"Lambert","year":"2019","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib32","doi-asserted-by":"crossref","first-page":"e9739","DOI":"10.1371\/journal.pone.0009739","article-title":"First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis","volume":"5","author":"Kraus","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.joca.2021.04.019_bib33","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.joca.2015.03.036","article-title":"Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use","volume":"23","author":"Kraus","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.berh.2005.09.001","article-title":"Do biochemical markers have a role in osteoarthritis diagnosis and treatment?","volume":"20","author":"Kraus","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.joca.2021.04.019_bib35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1053\/joca.2002.0821","article-title":"A\u00a0comparative analysis of bone and cartilage metabolism in two strains of Guinea-pig with varying degrees of naturally occurring osteoarthritis","volume":"10","author":"Huebner","year":"2002","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib36","doi-asserted-by":"crossref","first-page":"453s","DOI":"10.1093\/ajcn\/nqaa036","article-title":"Standardization of laboratory practices and reporting of biomarker data in clinical nutrition research","volume":"112","author":"O'Callaghan","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.joca.2021.04.019_bib37","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables","volume":"332","author":"Altman","year":"2006","journal-title":"Br Med J"},{"key":"10.1016\/j.joca.2021.04.019_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00223-020-00701-7","article-title":"Osteoarthritis: current molecular biomarkers and the way forward","volume":"109","author":"Kraus","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.joca.2021.04.019_bib39","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.joca.2007.01.016","article-title":"The ratio of type II collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis","volume":"15","author":"Cahue","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00011-003-1177-5","article-title":"Neoepitopes as biomarkers of cartilage catabolism","volume":"52","author":"Fosang","year":"2003","journal-title":"Inflamm Res"},{"key":"10.1016\/j.joca.2021.04.019_bib41","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.joca.2017.04.004","article-title":"Quantification of cartilage oligomeric matrix protein (COMP) and a COMP neoepitope in synovial fluid of patients with different joint disorders by novel automated assays","volume":"25","author":"Lorenzo","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib42","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3109\/1354750X.2011.620628","article-title":"A\u00a0novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M)","volume":"16","author":"Leeming","year":"2011","journal-title":"Biomarkers"},{"key":"10.1016\/j.joca.2021.04.019_bib43","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/j.pain.0000000000000908","article-title":"Biomarker of extracellular matrix remodelling C1M and proinflammatory cytokine interleukin 6 are related to synovitis and pain in end-stage knee osteoarthritis patients","volume":"158","author":"Radojcic","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.joca.2021.04.019_bib44","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.joca.2017.07.015","article-title":"Effects of dietary weight loss with and without exercise on interstitial matrix turnover and tissue inflammation biomarkers in adults with knee osteoarthritis: the Intensive Diet and Exercise for Arthritis trial (IDEA)","volume":"25","author":"Loeser","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib45","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.joca.2017.09.007","article-title":"Safety, tolerability, and pharmacodynamics of an anti-interleukin-1alpha\/beta dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study","volume":"25","author":"Wang","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib46","series-title":"Biomarkers in Disease: Methods, Discoveries and Applications","first-page":"1","article-title":"Bone biomarkers related to osteoarthritis","author":"Engbersen","year":"2016"},{"key":"10.1016\/j.joca.2021.04.019_bib47","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/annrheumdis-2016-209252","article-title":"Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium","volume":"76","author":"Kraus","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2021.04.019_bib48","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.61.6.530","article-title":"Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products","volume":"61","author":"Lehmann","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2021.04.019_bib49","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S8756-3282(00)00248-9","article-title":"Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy","volume":"26","author":"Christgau","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.joca.2021.04.019_bib50","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00228-006-0174-3","article-title":"An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice","volume":"62","author":"Leeming","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.joca.2021.04.019_bib51","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/art.38739","article-title":"Alpha C-telopeptide of type I collagen is associated with subchondral bone turnover and predicts progression of joint space narrowing and osteophytes in osteoarthritis","volume":"66","author":"Huebner","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2021.04.019_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00264-004-0608-4","article-title":"Elevated levels of serum type I collagen C-telopeptide in patients with rapidly destructive osteoarthritis of the hip","volume":"29","author":"Berger","year":"2005","journal-title":"Int Orthop"},{"key":"10.1016\/j.joca.2021.04.019_bib53","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2217\/WHE.11.74","article-title":"Use of bone turnover markers in clinical osteoporosis assessment in women: current issues and future options","volume":"7","author":"Henriksen","year":"2011","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.joca.2021.04.019_bib54","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1152\/physrev.1989.69.3.990","article-title":"Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone","volume":"69","author":"Hauschka","year":"1989","journal-title":"Physiol Rev"},{"issue":"Suppl 2","key":"10.1016\/j.joca.2021.04.019_bib55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/13697137.2015.1101256","article-title":"Role of biochemical markers in the management of osteoporosis","volume":"18","author":"Henriksen","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.joca.2021.04.019_bib56","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.joca.2013.03.008","article-title":"Diagnostic and prognostic value of bone biomarkers in progressive knee osteoarthritis: a 6-year follow-up study in middle-aged subjects","volume":"21","author":"Kumm","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib57","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ndt\/gfr270","article-title":"Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients","volume":"27","author":"Cejka","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 120","key":"10.1016\/j.joca.2021.04.019_bib58","first-page":"73","article-title":"Biochemical markers in osteoarthritis with lessons learned from osteoporosis","volume":"37","author":"Karsdal","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.joca.2021.04.019_bib59","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/art.20332","article-title":"A\u00a0new marker for osteoarthritis: cross-sectional and longitudinal approach","volume":"50","author":"Reijman","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2021.04.019_bib60","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.joca.2014.12.019","article-title":"Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials","volume":"23","author":"Karsdal","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib61","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00198-008-0603-5","article-title":"The effects of oral calcitonin on bone collagen maturation: implications for bone turnover and quality","volume":"19","author":"Karsdal","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.joca.2021.04.019_bib62","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/0091270008329552","article-title":"A\u00a0pharmacokinetic and pharmacodynamic comparison of synthetic and recombinant oral salmon calcitonin","volume":"49","author":"Karsdal","year":"2009","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.joca.2021.04.019_bib63","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/jor.23720","article-title":"Mechanically stimulated biomarkers signal cartilage changes over 5 years consistent with disease progression in medial knee osteoarthritis patients","volume":"36","author":"Chu","year":"2018","journal-title":"J\u00a0Orthop Res"},{"key":"10.1016\/j.joca.2021.04.019_bib64","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.joca.2015.04.022","article-title":"Type II collagen C2C epitope in human synovial fluid and serum after knee injury - associations with molecular and structural markers of injury","volume":"23","author":"Kumahashi","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib65","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.joca.2013.10.020","article-title":"Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover","volume":"22","author":"Siebuhr","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1472-6882-14-159","article-title":"Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial","volume":"14","author":"Henrotin","year":"2014","journal-title":"BMC Compl Alternative Med"},{"key":"10.1016\/j.joca.2021.04.019_bib67","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1080\/14737159.2019.1646641","article-title":"Coll2-1 and Coll2-1NO2 as exemplars of collagen extracellular matrix turnover - biomarkers to facilitate the treatment of osteoarthritis?","volume":"19","author":"Mobasheri","year":"2019","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.joca.2021.04.019_bib68","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.joca.2015.04.011","article-title":"Association of urinary biomarker COLL2-1NO(2) with incident clinical and radiographic knee OA in overweight and obese women","volume":"23","author":"Landsmeer","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib69","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.10576","article-title":"Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis","volume":"46","author":"Garnero","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2021.04.019_bib70","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1947603519828432","article-title":"Knee joint distraction compared with high tibial osteotomy and total knee arthroplasty: two-year clinical, radiographic, and biochemical marker outcomes of two randomized controlled trials","volume":"12","author":"Jansen","year":"2021","journal-title":"Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib71","first-page":"430","article-title":"Serum concentrations of type II collagen biomarkers (C2C, C1, 2C and CPII) suggest different pathophysiologies in patients with hip osteoarthritis","volume":"26","author":"Conrozier","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.joca.2021.04.019_bib72","doi-asserted-by":"crossref","first-page":"18789","DOI":"10.3390\/ijms151018789","article-title":"Cartilage turnover reflected by metabolic processing of type II collagen: a novel marker of anabolic function in chondrocytes","volume":"15","author":"Gudmann","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.joca.2021.04.019_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113485","article-title":"A\u00a0novel high sensitivity type II collagen blood-based biomarker, PRO-C2, for assessment of cartilage formation","volume":"19","author":"Luo","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.joca.2021.04.019_bib74","first-page":"S61","article-title":"Identification of superior responders to a bone and cartilage centric treatment in osteoarthritis: low levels of cartilage formation may provide an opportunity to stimulate formation Osteoarthritis","volume":"27","author":"Luo","year":"2019","journal-title":"Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib75","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.joca.2019.01.001","article-title":"Potential diagnostic value of a type X collagen neo-epitope biomarker for knee osteoarthritis","volume":"27","author":"He","year":"2019","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib76","series-title":"Association between Concentrations of Urinary Type II Collagen Neoepitope (uTIINE) and Joint Space Narrowing in Patients with Knee Osteoarthritis","author":"Hellio Le Graverand","year":"2006"},{"key":"10.1016\/j.joca.2021.04.019_bib77","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13075-016-0976-3","article-title":"Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort","volume":"18","author":"Saberi Hosnijeh","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2021.04.019_bib78","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/joca.2002.0819","article-title":"Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis","volume":"10","author":"Vilim","year":"2002","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib79","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/art.20365","article-title":"Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years","volume":"50","author":"Sharif","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2021.04.019_bib80","article-title":"The effect of protease inhibitors on the induction of osteoarthritis-related biomarkers in bovine full-depth cartilage explants","volume":"10","author":"He","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.joca.2021.04.019_bib81","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.joca.2015.02.778","article-title":"Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification","volume":"23","author":"Larkin","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2021.04.019_bib82","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/art.22599","article-title":"Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation","volume":"56","author":"Karsdal","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2021.04.019_bib83","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar2434","article-title":"Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity","volume":"10","author":"Karsdal","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2021.04.019_bib84","doi-asserted-by":"crossref","first-page":"11328","DOI":"10.1038\/s41598-020-68077-0","article-title":"Multivariable logistic and linear regression models for identification of clinically useful biomarkers for osteoarthritis","volume":"10","author":"Liem","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.joca.2021.04.019_bib85","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/art.1780380608","article-title":"Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee","volume":"38","author":"Sharif","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2021.04.019_bib86","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2474-15-93","article-title":"The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases","volume":"15","author":"Sun","year":"2014","journal-title":"BMC Muscoskel Disord"},{"key":"10.1016\/j.joca.2021.04.019_bib87","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/ard.2004.022434","article-title":"MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis","volume":"64","author":"Tchetverikov","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2021.04.019_bib88","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/art.21345","article-title":"Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis","volume":"52","author":"Lohmander","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2021.04.019_bib89","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13075-015-0913-x","article-title":"Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study","volume":"18","author":"Bay-Jensen","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2021.04.019_bib90","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/art.40527","article-title":"Translational biomarkers and ex vivo models of joint tissues as a tool for drug development in rheumatoid arthritis","volume":"70","author":"Kjelgaard-Petersen","year":"2018","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2021.04.019_bib91","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar4266","article-title":"Serological identification of fast progressors of structural damage with rheumatoid arthritis","volume":"15","author":"Siebuhr","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2021.04.019_bib92","first-page":"1","article-title":"Blood and urinary collagen markers in osteoarthritis: markers of tissue turnover and disease activity","author":"Bay-Jensen","year":"2019","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.joca.2021.04.019_bib93","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0169-409X(91)90003-U","article-title":"Clearance of hyaluronan from the circulation","volume":"7","author":"Lebel","year":"1991","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.joca.2021.04.019_bib94","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/17460441.2018.1465922","article-title":"Recent advances in automated protein design and its future challenges","volume":"13","author":"Setiawan","year":"2018","journal-title":"Expet Opin Drug Discov"},{"key":"10.1016\/j.joca.2021.04.019_bib95","first-page":"1","article-title":"Clinical development success rates 2006-2015. Biotechnology Innovation Organization (BIO)","author":"Thomas","year":"2016","journal-title":"Biomedtracker Amp"},{"key":"10.1016\/j.joca.2021.04.019_bib96","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/ar2839","article-title":"Biomarkers: in combination they may do better","volume":"11","author":"Williams","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2021.04.019_bib97","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1074\/mcp.R120.002234","article-title":"Single-cell proteomics: progress and prospects","volume":"19","author":"Kelly","year":"2020","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.joca.2021.04.019_bib98","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jncimonographs\/lgr010","article-title":"Biobankonomics: a taxonomy for evaluating the economic benefits of standardized centralized human biobanking for translational research","volume":"2011","author":"Rogers","year":"2011","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"key":"10.1016\/j.joca.2021.04.019_bib99","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1378\/chest.15-0296","article-title":"Clinical drug development using dynamic biomarkers to enable personalized health care in COPD","volume":"148","author":"Bihlet","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.joca.2021.04.019_bib100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1602\/neurorx.1.2.189","article-title":"Biomarkers and surrogate markers: An FDA Pperspective","volume":"1","author":"Katz","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.joca.2021.04.019_bib101","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13075-021-02610-y","article-title":"A matrix metalloproteinase-generated neoepitope of CRP can identify knee and multi-joint inflammation in osteoarthritis","volume":"23","author":"Alexander","year":"2021","journal-title":"Arthritis Res Ther"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458421008839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458421008839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:57:20Z","timestamp":1761019040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458421008839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":101,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1063458421008839"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2021.04.019","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical monitoring in osteoarthritis: Biomarkers","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2021.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Osteoarthritis Research Society International. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}